OncLive® On Air cover image

S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer

OncLive® On Air

00:00

ASCENT‑03: first‑line SG crossover effects

Heather McArthur reviews ASCENT‑03 first‑line PFS benefit with crossover likely obscuring overall survival differences.

Play episode from 08:23
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app